Exozymes (EXOZ) Operating Expenses (2023 - 2026)
Exozymes (EXOZ) posted quarterly Operating Expenses of $2.7 million for Q4 2025, up 35.91% year-over-year from $2.0 million in Q4 2024, and up 6.87% quarter-over-quarter from $2.5 million in Q3 2025.
Exozymes (EXOZ) Operating Expenses (2023 - 2026) Analysis & Trends
Exozymes (EXOZ) has reported Operating Expenses for 3 consecutive years, with $2.7 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Operating Expenses rose 35.91% year-over-year to $2.7 million; the TTM figure through Dec 2025 stood at $9.7 million (up 63.79% YoY), while the FY2025 annual figure was $9.7 million, up 63.79% from the prior year.
- Operating Expenses grew to $2.7 million in Q4 2025 per EXOZ's latest filing, from $2.5 million in the prior quarter.
- Across five years, Operating Expenses topped out at $2.7 million in Q4 2025 and bottomed at $391846.0 in Q3 2023.
- Historically, Operating Expenses has averaged $1.7 million across 3 years, with a median of $1.8 million in 2024.
- Annual changes were most pronounced in 2024 — Operating Expenses jumped 311.32% — and 2025, when it soared 35.91%.
- Exozymes' Operating Expenses stood at $984347.0 in 2023, then surged by 101.49% to $2.0 million in 2024, then jumped by 35.91% to $2.7 million in 2025.
- Business Quant data shows EXOZ's Operating Expenses at $2.7 million in Q4 2025, $2.5 million in Q3 2025, and $2.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.06 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 427.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 541.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -784.57 Mn |
| 10 | Exozymes | 61.53 Mn | 61.53 Mn | - | 2.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.95 Mn |
| Dec 31, 2025 | 2.70 Mn |
| Sep 30, 2025 | 2.52 Mn |
| Jun 30, 2025 | 2.55 Mn |
| Mar 31, 2025 | 1.95 Mn |
| Dec 31, 2024 | 1.98 Mn |
| Sep 30, 2024 | 1.61 Mn |
| Jun 30, 2024 | 1.33 Mn |
| Mar 31, 2024 | 1.01 Mn |
| Dec 31, 2023 | 984,347.00 |
| Sep 30, 2023 | 391,846.00 |